Kiora Pharmaceuticals

Yahoo Finance • 2 months ago

Vicarious Surgical appoints Stephen From as new CEO

WALTHAM, Mass. - Surgical robotics company Vicarious Surgical Inc. (NYSE:RBOT), currently valued at $7.9 million in market capitalization, announced Thursday the appointment of Stephen From as Chief Executive Officer and board member, effe... Full story

Yahoo Finance • 3 years ago

Kiora’s stock rallies as eye drop treatment moves into mid-stage clinical trial

MARKET PULSE Shares of Kiora Pharmaceuticals Inc. (KPRX) soared about 57% in premarket trading on Tuesday after the company said it will begin a Phase 2 clinical trial for its experimental eye drops as a treatment for ocular rheumatoid art... Full story